Skip navigation

Eetu Koski as CEO

Briefing | Leena Manner | 01.06.2018

Medication robotics company Evondos Ltd, based in Salo, has appointed M.Sc. (Econ.) Eetu Koski as CEO as of today. The interim CEO Stefan Zilliacus will remain in a Senior Adviser position until August.

“The Board was looking for a person with drive, industry specific skills and ability to create a performance driven culture in the skilled Evondos team. We believe that Eetu Koski will fulfil these expectations. He has a long, over 20 years of international experience from the healthtech sector. In his previous positions, he has managed a substantial growth in sales and also profitability – both factors very important for Evondos, too,” says Chairman of Evondos Board, Wenche Rolfsen.

“Evondos is a smart innovation in the very attractive and interesting healthcare business. The company is offering a robotized medicine dispensing service already used in over 80 municipalities in the Nordics, with over a million safely and securely delivered medicine doses. The need for robotized medicine service is in a catch up phase globally, and it is growing fast. It is a very interesting opportunity to be able to accelerate further growth in this new market category with Evondos’ innovative service to the wider healthcare audiences. The service brings medical safety in home care into a completely new level while offering more time for the stressed out home care personnel and cost savings for the service providing municipalities, Eetu Koski points out his reasons for joining the Evondos team.

Evondos has sales offices in Norway, Sweden and Denmark while over 60% of sales comes from exports, mainly from Norway. The company employs ca 70 persons, of which ca 50 in Finland where the manufacturing and R&D also take place.

At the end of 2018, the service is estimated to be in use by ca 2,500 end-users, bringing net sales of over 4 million euros.  At the end of 2017, the company signed an investment agreement with a Norwegian investment company Serendipity Partners, which become the single largest owner of the company. The investment round was over 20 million euros in total.

Further information:
Eetu Koski, CEO of Evondos
Wenche Rolfsen, Chairman of the Board of Evondos, tel.  +46 733 319 156

Eetu Koski, 46
Work experience: CEO and consultant, private investor, country manager
Career in: Health Tech Partners, Convatec, Algol Diagnostics, Nestle Health Care, Novartis Finland, Serres
Education: M.Sc. (Econ.)
Family: wife and one child
Hobbies: Tennis, swimming, travelling, reading, theatre and museums

Share article